Postpartum-depression trial using Neuronetics' TMS device begins

08/1/2013 | (Boston)

Neuronetics has begun patient enrollment in a clinical study to test the use of its NeuroStar transcranial magnetic stimulation, or TMS, system in patients with postpartum depression. The outpatient procedure, which takes 37 minutes, was cleared by the FDA for depression patients who have failed to respond to conventional drug therapy.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT